The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type - Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

被引:83
|
作者
Castano, EM
Prelli, F
Soto, C
Beavis, R
Matsubara, E
Shoji, M
Frangione, B
机构
[1] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016
[3] GUNMA UNIV,SCH MED,DEPT NEUROL,GUNMA 371,JAPAN
关键词
D O I
10.1074/jbc.271.50.32185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCEFWA-D), a genetic variant (E22Q) of amyloid beta (A beta) accumulates predominantly in the small vessels of leptomeninges and cerebral cortex, leading to fatal strokes in the fifth or sixth decade of life, A beta deposition in the neuropil occurs mainly in the form of preamyloid, Congo red negative deposits, while mature neuritic plaques and neurofibrillary tangles, hallmark lesions in Alzheimer's disease (AD), are characteristically absent, A recent hypothesis regarding the patho genesis of AD states that A beta extending to residues 42-43 (as opposed to shorter species) can seed amyloid formation and trigger the development of neuritic plaques followed by neuronal damage in AD. We characterized biochemically and immunohistochemically A beta from three cases of HCHWA-D to determine its length in vascular and parenchymal deposits, Mass spectrometry of formic acid-soluble amyloid, purified by size-exclusion gel chromatography, showed that A beta 1-40 and its carboxyl-terminal truncated derivatives were the predominant forms in leptomeningeal and cortical vessels, A beta 1-42 was a minor component in these amyloid extracts, Immunohistochemistry with antibodies S40 and S42, specific for A beta ending at Val-40 or Ala-42, respectively, were consistent with the biochemical data from vascular amyloid. In addition, parenchymal preamyloid lesions were specifically stained with S42 and were not labeled by S40, in agreement with the pattern reported for AD, Down's syndrome, and aged dogs, Our results suggest that in HCHWA-D the carboxyl-terminal A beta heterogeneity is due to limited proteolysis in vivo, Moreover, they suggest that A beta species ending at Ala-42 may not be critical for the seeding of amyloid formation and the development of AD-like neuritic changes.
引用
收藏
页码:32185 / 32191
页数:7
相关论文
共 50 条
  • [21] Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach
    Bartolini, Manuela
    Naldi, Marina
    Fiori, Jessica
    Valle, Francesco
    Biscarini, Fabio
    Nicolau, Dan V.
    Andrisano, Vincenza
    ANALYTICAL BIOCHEMISTRY, 2011, 414 (02) : 215 - 225
  • [22] Single Molecule Fluorescence Studies of Amyloid-Beta 1-42 Aggregation
    Flint, Jennie A.
    Narayan, Priyanka
    Horrocks, Mathew H.
    Shammas, Sarah L.
    Klenerman, David
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 443A - 443A
  • [23] Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegansfor drug screening for Alzheimer’s disease
    Gawain McColl
    Blaine R Roberts
    Tara L Pukala
    Vijaya B Kenche
    Christine M Roberts
    Christopher D Link
    Timothy M Ryan
    Colin L Masters
    Kevin J Barnham
    Ashley I Bush
    Robert A Cherny
    Molecular Neurodegeneration, 7
  • [24] Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of Alzheimer's disease
    Shallie, Oluwadamilola F.
    Dalle, Ernest
    Mabandla, Musa V.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2020, 169
  • [25] Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
    McColl, Gawain
    Roberts, Blaine R.
    Pukala, Tara L.
    Kenche, Vijaya B.
    Roberts, Christine M.
    Link, Christopher D.
    Ryan, Timothy M.
    Masters, Colin L.
    Barnham, Kevin J.
    Bush, Ashley I.
    Cherny, Robert A.
    MOLECULAR NEURODEGENERATION, 2012, 7
  • [26] Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease
    Philippens, Ingrid H.
    Ormel, Paul R.
    Baarends, Guus
    Johansson, Maja
    Remarque, Ed J.
    Doverskog, Magnus
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (01) : 101 - 113
  • [27] Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer’s Disease
    Chuan He
    Zhong-sheng Huang
    Chao-chao Yu
    Hai-hua Wang
    Hua Zhou
    Li-hong Kong
    Current Medical Science, 2020, 40 : 1022 - 1030
  • [28] Amyloid-beta and tau protein beyond Alzheimer's disease
    Morteza Abyadeh
    Vivek Gupta
    Joao A.Paulo
    Arezoo Gohari Mahmoudabad
    Sina Shadfar
    Shahab Mirshahvaladi
    Veer Gupta
    Christine T.O.Nguyen
    David I.Finkelstein
    Yuyi You
    Paul A.Haynes
    Ghasem H.Salekdeh
    Stuart L.Graham
    Mehdi Mirzaei
    Neural Regeneration Research, 2024, (06) : 1262 - 1276
  • [29] RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
    Yan, SD
    Chen, X
    Fu, J
    Chen, M
    Zhu, HJ
    Roher, A
    Slattery, T
    Zhao, L
    Nagashima, M
    Morser, J
    Migheli, A
    Nawroth, P
    Stern, D
    Schmidt, AM
    NATURE, 1996, 382 (6593) : 685 - 691
  • [30] Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain
    Wildburger, Norelle C.
    Esparza, Thomas J.
    LeDuc, Richard D.
    Fellers, Ryan T.
    Thomas, Paul M.
    Cairns, Nigel J.
    Kelleher, Neil L.
    Bateman, Randall J.
    Brody, David L.
    SCIENTIFIC REPORTS, 2017, 7